Latest Zyprexa Stories
INDIANAPOLIS, July 22 /PRNewswire-FirstCall/ -- Nine percent revenue growth driven by higher volume continues strong trend for the year.21 percent of Q2 revenue invested in R&D to advance pipeline of nearly 70 potential new medicines in clinical development.Ongoing cost-containment efforts support double-digit growth in operating income.Q2 earnings per share grow to $1.22 (reported), or $1.24 (non-GAAP).2010 earnings per share guidance range raised to $4.44 to $4.59 (reported), or $4.50...
- One of the side scenes of the stage in a theater, or the space included between the side scenes.
- The outside stock exchange, or “curb market,” of Paris.
- A flute or groove on the blade of a sword.
- A section of stage scenery placed in a wing of a theatre.